Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results

November 14, 2018

Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results

November 8, 2018

Titan Strengthens Executive Leadership Team With Appointment Of Chief Commercial Officer

October 2, 2018

Titan Pharmaceuticals Prices $9,500,000 Public Offering

September 20, 2018

Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse

September 10, 2018

Titan And The Nevada Center For Behavioral Health Collaborate To Evaluate Probuphine® Treament Of OUD Patients Within The State Of Nevada Criminal Justice System

September 4, 2018

Titan Pharmaceuticals Reports Second Quarter 2018 Financial Results

August 14, 2018

Titan Announces Amendment To Agreement With Molteni

August 3, 2018

Titan Pharmaceuticals Provides Update On Parkinson's Disease Clinical Development Program

July 2, 2018

Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence

May 30, 2018

  • 1
  • 2
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter